Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 26, 2015 6:52 PM ET

Diversified Consumer Services

Company Overview of University of Oxford

Company Overview

University of Oxford is an educational institution that provides undergraduate, graduate, research, and distance learning programs. It offers courses in humanities; physical and life sciences; medical sciences; mathematics; social sciences; archaeology and anthropology; biological sciences; biochemistry; chemistry; and economics and management. The university was founded in 1096 and is based in Oxford, United Kingdom.

Wellington Square

Oxford,  OX1 2JD

United Kingdom

Founded in 1096


44 1865 270000


44 18 6527 0708

Key Executives for University of Oxford

Director of Finance
Age: 56
President of Kellogg College at Oxford University and Director of the Department for Continuing Education
Human Resources Director
Compensation as of Fiscal Year 2015.

University of Oxford Key Developments

Summit Therapeutics and University of Oxford Announce Multi-Year Extension of Strategic Alliance

Summit Therapeutics plc announced a multi-year extension of its strategic alliance with the University of Oxford until November 2019, with an option to extend it for a further 12 months, to support and accelerate development of future generation utrophin modulators for the treatment of the progressive muscle wasting disorder, DMD. Under the terms of the alliance extension, Summit retains an exclusive option to arising intellectual property (IP) in the field of utrophin modulation generated during the term of the collaboration. Summit will also continue to sponsor a drug discovery and development programme in the University of Oxford research laboratories to identify and develop oral utrophin modulators for the treatment of DMD. This research programme, originally running to November 2016, will now continue until November 2019 with an option to extend it for a further 12 months. As part of the extension, Summit will increase the funding to £0.83 million a year starting in November 2015. Isis Innovation Limited (Isis) continues to hold warrants over 354,090 ordinary shares that were granted as part of the original alliance agreement signed in 2013. All the warrants may be exercised by Isis by February 2020, three months after the end of the alliance extension, subject to achieving key research, development and regulatory milestones.

University of Oxford Presents at ICBI's Super Investor 2015, Nov-17-2015 through Nov-20-2015

University of Oxford Presents at ICBI's Super Investor 2015, Nov-17-2015 through Nov-20-2015. Venue: Hotel Okura, Amsterdam, Netherlands. Presentation Date & Speakers: Nov-19-2015, Tim Jenkinson, Professor of Finance, Private Equity Institute, SAID BUSINESS SCHOOL. Nov-20-2015, Tim Jenkinson, Professor of Finance, Private Equity Institute, SAID BUSINESS SCHOOL.

European Investment Bank Provides GBP 200 Million for Oxford University's Programme of Improvement and Expansion of Research and Teaching Facilities

The European Investment Bank (EIB) has agreed to provide GBP 200 million for Oxford University's programme of improvement and expansion of research and teaching facilities. This represents the large ever single loan for university investment by Europe's long-term lending institution. The 30 year loan from the internationally owned public bank will be used alongside other sources of financing, including grants and philanthropic donations, towards the University's plans to replace and upgrade existing buildings across Oxford including the Radcliffe Observatory Quarter and to expand the Old Road Campus on the former Park Hospital site. The money has been allocated both to planned buildings and projects that have already been completed. The new investment programme backed by the European Investment Bank loan will strengthen specialised scientific research at the university. New laboratories for interdisciplinary bioscience will be built at the heart of the South Parks Road Science Area, building on the legacy of Oxford Nobel Prize winners such as Howard Florey, Hans Krebs, Dorothy Hodgkin and Paul Nurse. Research and teaching at the Department of Physics will benefit from new facilities with very low vibration levels and excellent temperature control linked on three levels to the existing Clarendon Laboratory. This new building, called the Beecroft Building, is currently under construction.

Similar Private Companies By Industry

Company Name Region
Hopscotch Solutions Limited Europe
Falck Nutec Ltd Europe
Maritime Training and Competence Solutions Ltd. Europe
Univent Plc Europe
BeGo Ltd. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact University of Oxford, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at